Type I interferons for induction of remission in ulcerative colitis-Reference-Cited by-同舟云学术

Type I interferons for induction of remission in ulcerative colitis

Published:2015-09-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wang Yongjun¹,MacDonald John K¹,Benchimol Eric I²,Griffiths Anne Marie³,Steinhart A Hillary⁴,Panaccione Remo⁵,Seow Cynthia H⁶

Affiliation:

1. Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada

2. The Children's Hospital of Eastern Ontario; CHEO Inflammatory Bowel Disease Centre, Division of Gastroenterology Hepatology & Nutrition; 401 Smyth Road Ottawa ON Canada K1H 8L1

3. The Hospital for Sick Children; Division of Gastroenterology, Hepatology & Nutrition; 555 University Ave. Toronto ON Canada M5G 1X8

4. Mount Sinai Hospital; Department of Medicine, Division of Gastroenterology; Room 445, 600 University Avenue Toronto ON Canada M5G 1X5

5. University Of Calgary; Calgary AB Canada

6. University of Calgary; Department of Medicine; TRW Building Rm 6D18 3280 Hospital Drive NW Calgary AB Canada T2N 4Z6

Publisher

Wiley

Subject

Pharmacology (medical)

Reference86 articles.

1. An open, randomized study comparing systemic interferon-a-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis;Madsen;Gut,1999

2. An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis;Madsen;American Journal of Gastroenterology,2001

3. Mucosal healing an essential efficacy measure in ulcerative colitis: Effect of country-enrollment site in a phase IIa study with interferon-ß-1a;Mannon;Journal of Crohn's and Colitis,2011

4. Secondary efficacy analysis from a phase IIa multicenter study with interferon-ß-1a for induction of clinical response in active moderate to severe ulcerative colitis;Mannon;American Journal of Gatroenterology,2010

5. Interferon-ß-1a in active moderate to severe ulcerative colitis: Efficacy and safety from a phase IIa multicenter study;Mannon;American Journal of Gastroenterology,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for targeting cytokines in inflammatory bowel disease;Nature Reviews Immunology;2024-03-14

2. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases;Frontiers in Immunology;2021-10-12

3. The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection;Frontiers in Immunology;2021-07-21

4. Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease;Frontiers in Immunology;2021-06-24

5. Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation;Phytomedicine;2021-04